184 related articles for article (PubMed ID: 33530497)
41. Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.
Kobayashi H; Ogawa K; Kawahara N; Iwai K; Niiro E; Morioka S; Yamada Y
Free Radic Res; 2017 Oct; 51(9-10):755-764. PubMed ID: 28931330
[TBL] [Abstract][Full Text] [Related]
42. High-Grade Serous Carcinoma Involving Fallopian Tube, Ovary and Peritoneum.
Al-Agha OM; Blake Gilks C
Surg Pathol Clin; 2011 Mar; 4(1):375-96. PubMed ID: 26837299
[TBL] [Abstract][Full Text] [Related]
43. Taking the Tube: From Normal Fallopian Tube Epithelium to Ovarian High-grade Serous Carcinoma.
Tone AA
Clin Obstet Gynecol; 2017 Dec; 60(4):697-710. PubMed ID: 29045296
[TBL] [Abstract][Full Text] [Related]
44. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Vang R; Shih IeM; Kurman RJ
Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
[TBL] [Abstract][Full Text] [Related]
45. Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.
Dean M; Davis DA; Burdette JE
Cancer Lett; 2017 Apr; 391():114-124. PubMed ID: 28115208
[TBL] [Abstract][Full Text] [Related]
46. Mutant p53 expression in fallopian tube epithelium drives cell migration.
Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
[TBL] [Abstract][Full Text] [Related]
47. Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
Ohsuga T; Yamaguchi K; Kido A; Murakami R; Abiko K; Hamanishi J; Kondoh E; Baba T; Konishi I; Matsumura N
BMC Cancer; 2017 Aug; 17(1):580. PubMed ID: 28851311
[TBL] [Abstract][Full Text] [Related]
48. Haemoglobin in pelvic fluid rescues Fallopian tube epithelial cells from reactive oxygen species stress and apoptosis.
Huang HS; Hsu CF; Chu SC; Chen PC; Ding DC; Chang MY; Chu TY
J Pathol; 2016 Dec; 240(4):484-494. PubMed ID: 27625309
[TBL] [Abstract][Full Text] [Related]
49. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.
Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R
Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162
[TBL] [Abstract][Full Text] [Related]
50. Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma.
Jiang RT; Yemelyanova A; Xing D; Anchoori RK; Hamazaki J; Murata S; Seidman JD; Wang TL; Roden RBS
J Ovarian Res; 2017 Aug; 10(1):53. PubMed ID: 28784174
[TBL] [Abstract][Full Text] [Related]
51. Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
Tang W; Feng X; Zhang S; Ren Z; Liu Y; Yang B; lv B; Cai Y; Xia J; Ge N
Cell Physiol Biochem; 2015; 36(3):1223-36. PubMed ID: 26138883
[TBL] [Abstract][Full Text] [Related]
52. An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population.
Singh RK; Dhadve A; Sakpal A; De A; Ray P
Sci Rep; 2016 Nov; 6():36612. PubMed ID: 27819360
[TBL] [Abstract][Full Text] [Related]
53. Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
Hardy LR; Pergande MR; Esparza K; Heath KN; Önyüksel H; Cologna SM; Burdette JE
Oncogene; 2019 Aug; 38(32):6003-6016. PubMed ID: 31296958
[TBL] [Abstract][Full Text] [Related]
54. Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium.
Yucer N; Holzapfel M; Jenkins Vogel T; Lenaeus L; Ornelas L; Laury A; Sareen D; Barrett R; Karlan BY; Svendsen CN
Sci Rep; 2017 Sep; 7(1):10741. PubMed ID: 28878359
[TBL] [Abstract][Full Text] [Related]
55. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
[TBL] [Abstract][Full Text] [Related]
56. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.
Novak M; Lester J; Karst AM; Parkash V; Hirsch MS; Crum CP; Karlan BY; Drapkin R
Gynecol Oncol; 2015 Oct; 139(1):104-11. PubMed ID: 26206555
[TBL] [Abstract][Full Text] [Related]
57. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
[TBL] [Abstract][Full Text] [Related]
58. Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition.
Au-Yeung G; Lang F; Azar WJ; Mitchell C; Jarman KE; Lackovic K; Aziz D; Cullinane C; Pearson RB; Mileshkin L; Rischin D; Karst AM; Drapkin R; Etemadmoghadam D; Bowtell DD
Clin Cancer Res; 2017 Apr; 23(7):1862-1874. PubMed ID: 27663592
[No Abstract] [Full Text] [Related]
59. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.
Yamamoto Y; Ning G; Howitt BE; Mehra K; Wu L; Wang X; Hong Y; Kern F; Wei TS; Zhang T; Nagarajan N; Basuli D; Torti S; Brewer M; Choolani M; McKeon F; Crum CP; Xian W
J Pathol; 2016 Mar; 238(4):519-530. PubMed ID: 26415052
[TBL] [Abstract][Full Text] [Related]
60. High-grade serous ovarian cancer 3 years after bilateral salpingectomy: A case report.
Sato E; Nakayama K; Ishikawa M; Nakamura K; Ishibashi T; Kyo S
Mol Clin Oncol; 2017 Feb; 6(2):201-203. PubMed ID: 28357094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
